Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
25 Sep 2024 |
AP01 |
Appointment of Dr Andreas Hoekema as a director on 1 September 2024
|
|
|
22 May 2024 |
AA |
Accounts for a small company made up to 31 December 2023
|
|
|
10 May 2024 |
CS01 |
Confirmation statement made on 9 May 2024 with updates
|
|
|
26 Feb 2024 |
PSC08 |
Notification of a person with significant control statement
|
|
|
22 Feb 2024 |
MA |
Memorandum and Articles of Association
|
|
|
22 Feb 2024 |
RESOLUTIONS |
Resolutions
-
RES10 ‐
Resolution of allotment of securities
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
16 Feb 2024 |
SH01 |
Statement of capital following an allotment of shares on 29 January 2024
|
|
|
16 Feb 2024 |
PSC07 |
Cessation of Advent Life Sciences Llp as a person with significant control on 29 January 2024
|
|
|
16 Feb 2024 |
PSC07 |
Cessation of Epidarex Capital Iii Uk Lp as a person with significant control on 29 January 2024
|
|
|
16 Feb 2024 |
AP01 |
Appointment of Ms Carmine Circelli as a director on 12 January 2024
|
|
|
16 Feb 2024 |
AP01 |
Appointment of Mr Robert Armstrong as a director on 12 January 2024
|
|
|
09 Feb 2024 |
AP01 |
Appointment of Ms Marie-Claire Peakman as a director on 12 January 2024
|
|
|
07 Feb 2024 |
TM01 |
Termination of appointment of Ali Tavassoli as a director on 12 January 2024
|
|
|
07 Feb 2024 |
TM01 |
Termination of appointment of Diana Felicity Galpin as a director on 12 January 2024
|
|
|
19 Jan 2024 |
MR01 |
Registration of charge 119899620001, created on 8 January 2024
|
|
|
18 Aug 2023 |
AA |
Accounts for a small company made up to 31 December 2022
|
|
|
10 May 2023 |
CS01 |
Confirmation statement made on 9 May 2023 with updates
|
|
|
27 Sep 2022 |
AA |
Accounts for a small company made up to 31 December 2021
|
|
|
10 May 2022 |
CS01 |
Confirmation statement made on 9 May 2022 with updates
|
|
|
31 Dec 2021 |
AA01 |
Previous accounting period shortened from 31 May 2022 to 31 December 2021
|
|
|
22 Oct 2021 |
AA |
Unaudited abridged accounts made up to 31 May 2021
|
|
|
30 May 2021 |
CS01 |
Confirmation statement made on 9 May 2021 with updates
|
|
|
16 May 2021 |
PSC05 |
Change of details for Advent Life Sciences Llp as a person with significant control on 12 May 2021
|
|
|
14 May 2021 |
CH01 |
Director's details changed for Dr Shahzad Malik on 12 May 2021
|
|
|
14 May 2021 |
SH01 |
Statement of capital following an allotment of shares on 14 May 2021
|
|